Specific Magnetic Bead–Based Capture of Genomic DNA from Clinical Samples: Application to the Detection of Group B Streptococci in Vaginal/Anal Swabs
Authors:
- François J PicardFPFrançois J Picard
- Régis PeytaviRPRégis Peytavi
- Martin GagnonMGMartin Gagnon
- Grégoire SeyrigGSGrégoire Seyrig
- Pier-Ann GagnéPGPier-Ann Gagné
- Maurice BoissinotMBMaurice Boissinot
- Michel G BergeronMBMichel G Bergeron
Open Access
- 1 September 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 53 (9) , 1570-1576
Abstract
Background: Group B streptococci (GBS) are a leading cause of sepsis and meningitis in newborns. We previously developed a rapid diagnostic system for GBS detection from vaginal/anal samples obtained from pregnant women during delivery. To facilitate the adaptation of this method for point-of-care testing, we have developed a specific and efficient GBS DNA capture method that is compatible with both PCR and nonamplification detection technologies. Methods: Superparamagnetic beads were functionalized with oligonucleotide capture probes of different lengths and used to capture GBS genomic DNA (gDNA). A rapid extraction procedure was used to provide DNA from GBS cultures or vaginal/anal samples with added GBS. Hybridization reactions consisting of functionalized beads and target DNA in 30 μL of hybridization buffer were performed for 1 h at room temperature, followed by washing and resuspension in water. Captured DNA was then detected using quantitative PCR. Results: A 25-mer capture probe allowed detection of 1000 genome copies of purified GBS DNA. The ability to detect GBS was improved by use of a 50-mer (100 copies) and a 70-mer capture probe (10 copies). Detection of approximately 1250 CFU/mL was achieved for diluted GBS broth culture and for vaginal/anal swab samples with added GBS. Conclusion: Oligonucleotide-functionalized superparamagnetic microbeads efficiently capture GBS gDNA from both bacterial cultures and vaginal/anal samples with added GBS. Efficiency of gDNA capture increases with oligonucleotide length. This technology could be combined with sample preparation and detection technologies in a microfluidic system to allow point-of-care testing for GBS.Keywords
Funding Information
- National Institutes of Health (1 U01 AI060594-01)
This publication has 37 references indexed in Scilit:
- High-Volume Extraction of Nucleic Acids by Magnetic Bead Technology for Ultrasensitive Detection of Bacteria in Blood ComponentsClinical Chemistry, 2007
- An Innovative, Flow-Assisted, Noncompetitive Chemiluminescent Immunoassay for the Detection of Pathogenic Bacteria,Clinical Chemistry, 2006
- Direct Molecular Detection of Nucleic Acids by Fluorescence Signal AmplificationJournal of the American Chemical Society, 2005
- Colorimetric and Fluorometric Detection of Nucleic Acids Using Cationic Polythiophene DerivativesAngewandte Chemie International Edition, 2002
- Rapid Detection of Group B Streptococci in Pregnant Women at DeliveryNew England Journal of Medicine, 2000
- Group B Streptococcal Disease in the Era of Intrapartum Antibiotic ProphylaxisNew England Journal of Medicine, 2000
- Immunomagnetic cell sorting—pushing the limitsImmunotechnology, 1998
- Solid-Phase Hybridization Capture of Low-Abundance Target DNA Sequences: Application to the Polymerase Chain Reaction Detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticumAnalytical Biochemistry, 1995
- Magnetic separation techniques in diagnostic microbiologyClinical Microbiology Reviews, 1994
- Nucleic acid sandwich hybridization: enhanced reaction rate with magnetic microparticles as carriersMolecular and Cellular Probes, 1988